David Hsiehchen

3 articles listing David Hsiehchen in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Domvanalimab plus zimberelimab in unresectable and immunotherapy refractory biliary tract cancers: a phase 2 trial Nature Communications
2. Deciphering small sequence differences in T cell receptor-antigen pairing Nature Communications
3. Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial Nature Communications